Abstract: Disclosed herein are several embodiments of medical device packaging, and more particularly to a reduced pressure therapy kit and packaging and methods of using the same in the treatment of wounds. Some embodiments are directed towards packaging including a dressing compartment for storing wound dressings and having use instructions printed thereon, the dressing compartment detachably connected to a pump compartment for storing a sterile pump. After removal of the pump, the pump compartment can be detached from the dressing compartment and discarded. The dressing compartment can be retained together with any additional dressings and the use instructions.

Abstract: Disclosed herein are several embodiments of medical device packaging, and more particularly to a reduced pressure therapy kit and packaging and methods of using the same in the treatment of wounds. Some embodiments are directed towards packaging including a dressing compartment for storing wound dressings and having use instructions printed thereon, the dressing compartment detachably connected to a pump compartment for storing a sterile pump. After removal of the pump, the pump compartment can be detached from the dressing compartment and discarded. The dressing compartment can be retained together with any additional dressings and the use instructions.

Abstract: Disclosed herein are several embodiments of medical device packaging, and more particularly to a reduced pressure therapy kit and packaging and methods of using the same in the treatment of wounds. Some embodiments are directed towards packaging including a dressing compartment for storing wound dressings and having use instructions printed thereon, the dressing compartment detachably connected to a pump compartment for storing a sterile pump. After removal of the pump, the pump compartment can be detached from the dressing compartment and discarded. The dressing compartment can be retained together with any additional dressings and the use instructions.

Abstract: The invention relates to a method of treatment of dementia and/or regression of cognitive function, comprising co-administration of effective amounts of an Angiotensin II antagonist and an Angiotensin I Converting Enzyme inhibitor, pharmaceutical compositions containing an Angiotensin II antagonist together with an ACE inhibitor and the use of an Angiotensin II antagonist and an ACE inhibitor for the manufacture of corresponding pharmaceutical compositions.

Abstract: The invention relates to a method of treatment of dementia and/or regression of cognitive function, comprising co-administration of effective amounts of an Angiotensin II antagonist and an Angiotensin I Converting Enzyme inhibitor, pharmaceutical compositions containing an Angiotensin II antagonist together with an ACE inhibitor and the use of an Angiotensin II antagonist and an ACE inhibitor for the manufacture of corresponding pharmaceutical compositions.

Abstract: The invention relates to a method of treatment of dementia and/or regression of cognitive function, comprising co-administration of effective amounts of an Angiotensin II antagonist and an Angiotensin I Converting Enzyme inhibitor, pharmaceutical compositions containing an Angiotensin II antagonist together with an ACE inhibitor and the use of an Angiotensin II antagonist and an ACE inhibitor for the manufacture of corresponding pharmaceutical compositions.

Abstract: The invention relates to a method of treatment of dementia and/or regression of cognitive function, comprising co-administration of effective amounts of an Angiotensin II antagonist and an Angiotensin I Converting Enzyme inhibitor, pharmaceutical compositions containing an Angiotensin II antagonist together with an ACE inhibitor and the use of an Angiotensin II antagonist and an ACE inhibitor for the manufacture of corresponding pharmaceutical compositions.